From the watch tracking steps on your wrist, to the phone compiling health data in your pocket, wearable technology is now part of our everyday lives. The rising popularity of wearable devices can even be seen in the physician’s office. Clinicians are leveraging wearable technology trends1 to benefit their patients and expand monitoring capabilities.
New innovations in extended ECG monitors are following consumer trends when it comes to wearable technology. However, you should select a device that works for both your patients and your practice. When exploring wearable ECG devices, it’s important to consider three things: 1) patient comfort and safety, 2) clinically robust data, and 3) the financial outcomes for your practice.
A positive patient experience is key when evaluating wearable devices for your practice. Help your patients take control of their heart health by choosing a wearable ECG device that is comfortable to wear, operates discretely and has little to no impact on your patient’s daily activities.
The Welch Allyn® TAGecg® Wearable Sensor is a discrete, wireless, water-resistant patch that does not disrupt a patient’s daily activities. After seven days of continuous ECG recording, the sensor is removed for data analysis and the patch is discarded.”„
Now that you’ve selected a patient-friendly device, it’s time to talk about the data you’re collecting. Today, many practices are considering patch-based solutions that can record for up to seven days and include instant analysis for most common arrhythmias. There are several devices available, so it’s helpful to keep a few criteria in mind when comparing wearable ECGs.
Monitoring periods or device wear-time can also affect the quality of your data. Studies have shown that 7-day monitoring improves atrial fibrillation (A-Fib) diagnostic yield when compared to shorter 24- and 48-hour methods.3
Sensitive enough to provide diagnostic-quality results with in-office reports, the Welch Allyn TAGecg Sensor provides timely data to help enable faster treatment decisions.„
The final piece to consider when exploring wearable technology is the financial impact these devices can have on your practice. In addition to delivering quality patient care, wearable ECG devices can also provide cost savings and greater access to reimbursements.
Practices that use the TAGecg Sensor can keep all reimbursement dollars associated with their ECG exam and report analysis. The device’s single-use, pay-as-you-go model offers a low-risk option for primary care practices and cardiology offices.„
There are many factors to explore when integrating wearable devices into your practice, but the decision becomes clearer when you consider your patients, your data and your bottom line. The wearable devices you select should focus on patient comfort and safety, without compromising data quality. And the financial benefits to your practice—from initial investment, to reimbursements and long-term savings—should not be overlooked.
At Hillrom, we understand the challenges of hard-to-detect arrhythmias like A-Fib, and the opportunities that wearable technology can provide for diagnosis and management. That’s why we developed the TAGecg Wearable Sensor—a new solution to help improve arrhythmia detection and diagnosis at the point of care. The TAGecg Sensor provides you with diagnostic-quality data, enabling you to maintain patient relationships while keeping diagnostic revenue within your practice. And with a patient-friendly design, the TAGecg Sensor can deliver the benefits of extended ECG monitoring without disrupting your patient’s daily activities.
1. Holbert, C. Wearable Technology Can Enhance Long Term Patient Care. Health Information Technology, August 3, 2017. https://www.beckershospitalreview.com/healthcare-information-technology/wearable-technology-canenhance-long-term-patient-care.html
2. Hougton, D E. ECG Equipment: Wired for Infection? Nursing. 2006 36, no. 12 (December 2006): 71. https://journals.lww.com/nursing/fulltext/2006/12000/ecg_equipment__wired_for_infection_.56.aspx.
3. Barrett, P M, et al. Comparison of 24-hour Holter Monitoring with 14-day Novel Adhesive Path Electrocardiographic Monitoring. Am J Med. 2014 Jan;127(1):95.e11-7. doi: 10.1016/j.amjmed.2013.10.003. Epub 2013 Oct 15.